Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer - Wikidata - awgldk - TriplyDB

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

http://www.wikidata.org/entity/Q36623452

about

Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer Whole genome expression profiling of blood cells in ovarian cancer patients -prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.miRNA Biomarkers in Breast Cancer Detection and Management Nutrition and the prevention and treatment of cancer: association of cytochrome P450 CYP1B1 with the role of fruit and fruit extracts.CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro.Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors.A novel methodology for enhanced and consistent heterologous expression of unmodified human cytochrome P450 1B1 (CYP1B1).Polycyclic aromatic hydrocarbons and cytochrome P450 in HIV pathogenesis.CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/β-Catenin Signaling via Sp1 Upregulation.Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer.Development of an In Vitro Model to Screen CYP1B1-Targeted Anticancer Prodrugs.IKK-ε coordinates invasion and metastasis of ovarian cancer.Cytochrome P450 1B1: a novel anticancer therapeutic target.Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management Pharmacogenetics and oncology treatment for breast cancer.CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine.A suite of activity-based probes for human cytochrome P450 enzymes.CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus.Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein.Unbalanced estrogen metabolism in ovarian cancer Pharmacogenetics of chemotherapy efficacy in breast cancer.Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review.The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC Cytochrome P450 CYP1B1 activity in renal cell carcinoma.Novel benzopyran derivatives and their therapeutic applications: a patent review (2009-2016).Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer.Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents.Progressive glomerulonephritis and histiocytic sarcoma associated with macrophage functional defects in CYP1B1-deficient mice.Molecular mechanisms of drug resistance in ovarian cancer.Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer.Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer.Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity.

P2860

Q33889096-612C2C8F-4144-426E-A910-C105D6EC2C15 Q33942459-6C60E58B-2A82-49AF-8920-4BE7A7E8C292 Q34100848-17998664-458A-4FAA-9BD4-B8DCC0ADCA99 Q34204238-FF186CCF-0E61-4074-91B5-985843C168C8 Q34771896-25DDF475-8087-4723-B1A1-97909056AC7A Q34912607-D1C6FF7E-A87E-4EAD-9156-C97D4AC03449 Q34936845-EC58B06E-6841-400B-9C9B-90C015BEBFCE Q35072792-2311A98E-B2B3-4FFB-821D-1858BBF7038B Q35349314-E910C765-F09B-4352-ADD8-7DBBC2A6E908 Q35672088-EB6EE981-FBF4-41AB-BFBD-6FD59E88CB8D Q35959168-6B0AD7CC-BA60-43CB-9451-4CB4B54A27B4 Q35966821-E26EEB19-2598-4F77-905B-242257718A16 Q36264616-3787C7F8-EC79-4863-B6D7-6049CCDEA207 Q36368532-E6F6280D-DA15-444A-AD1E-35BB0C7688FE Q36429453-D1EDC091-D5BB-41CD-8C56-BDA2104CBF17 Q36441485-9EBECE9E-95F2-4C01-B72D-6C214EF20D82 Q36719659-CC300A67-EFCB-4117-AA25-49BE7382F1F1 Q36857575-3FF1A58D-41C1-4C70-B3F9-34883ACBBACF Q37030810-8E945364-A385-4101-8550-D7B7A628A236 Q37259608-0ED74806-FED6-49E4-9725-09B5393F9C2F Q37331285-DD145838-1D1F-4A78-B69F-3D5B4970F283 Q37340998-BCD51E10-F6C3-4B0A-B06B-2BF0D58EADB2 Q37551896-BF8E8064-72DA-4704-BEFE-02A2E69798BD Q37629489-EC16D9AC-22A6-445A-A641-3A4276F77945 Q38003703-B0474307-D27C-407C-B066-E17FB962355F Q38551666-99454F16-7C87-4AFD-ACB8-E52D7F6A23A8 Q38622658-54FAFB31-46B3-41D0-A6F8-A0D6532BB95A Q38718489-57FF1FC6-935D-41C0-AAF6-7A49CD51C3C4 Q38800931-5308ED63-645B-406D-9FE7-7C611E02494D Q39382164-CFC0C01F-3E75-4C87-A095-199E879FC4EF Q39702921-7267DAA7-A730-482B-9B67-D7BC239190A9 Q41935784-5650EAFB-1FA4-42AF-8502-D93E5DADC444 Q45174463-5BF9F038-FF1E-47D1-8AF5-8832E5E945AE Q48274587-11BB663C-CED4-4A9B-82D0-4F5028DC9A5E Q50179674-50FA49BB-0FBB-449B-A5AB-8727AD0002BC Q50526560-2588A7FE-D96E-4701-8A63-A24F9557B5CD Q50557593-E415C5AB-5E8D-42C4-B39E-084CF91BB526 Q51764488-3B06271A-B88B-4113-8997-941B5A12FDEE

P2860

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

http://www.wikidata.org/entity/Q36623452

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

@ast

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

@en

type

label

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

@ast

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

@en

prefLabel

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

@ast

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

@en

P1433

Q36623452-23DC37E1-54F7-4C51-AC9E-A74F8100555F

P1476

Q36623452-F4B17F7F-D6B7-44B8-AA82-8EB9CCD27BE3

P2093

Q36623452-00579851-5902-417D-9815-964CBE4DCACC

Q36623452-0A70A0AB-313A-447E-8FBA-61D553EA3473

Q36623452-145A0AA5-4AA0-4824-B927-212A5116C2B5

Q36623452-2005DB12-48FE-4DC8-AA64-7E9C9A8E0986

Q36623452-259784C2-56EE-4B10-816F-05218752195E

Q36623452-900780EE-0487-4DCA-A94A-EA6B81CA9B3D

Q36623452-9F3D2E83-66CB-47D4-A44C-CA4544D0A2A5

P2860

Q36623452-030057F4-A418-4109-B8D1-CF6C1AB3A1A8

Q36623452-0859442D-633F-4EA3-B25A-35F33E709B43

Q36623452-106A38A5-336B-4B2B-A508-78C064815C16

Q36623452-1C8023C9-548D-47F5-8040-464AD3F2F58E

Q36623452-20EA84B3-D628-4574-80AF-375797351944

Q36623452-3F564203-F0EC-4C23-A014-C3FFE75EBF52

Q36623452-4325BDAC-7234-40BA-8A37-FE8092E6806C

Q36623452-45EBF3A3-D0BA-4E05-A160-FE11B6FFD6F0

Q36623452-47BB0B5E-7EB3-4D75-B034-FE14ABB28767

Q36623452-4F0B90D8-D5F9-41B8-ABC1-0C660467118D

P2888

Q36623452-C001010F-B75C-41D5-8674-61D406FC88A9

P304

Q36623452-5C547BC2-ECD6-44F9-B68F-5F3F90B35A84

P31

Q36623452-E5DE3241-0AC6-4C9F-B834-04EF8E9A87C3

P356

Q36623452-5B6CAE01-B7A0-4DDB-805D-DE285C1B52F2

P407

Q36623452-8DDD21BC-882E-48DB-A0A8-AADA3D1377B0

P433

Q36623452-A9107119-92F8-4943-95A5-748AD500D480

P478

Q36623452-7437B096-C8F9-4BF4-9F1B-17B472E5050A

P50

Q36623452-4D651E0D-C62C-4DAA-9AB7-E5F81A395FF2

P577

Q36623452-B9235359-6593-4245-B371-00D9B89BDCA6

P5875

Q36623452-87CC17A5-909E-4A5D-9A6A-D198D6D4C26C

P6179

Q36623452-99B75314-17A9-47C7-9EA0-0B65AC20B8BA

P698

Q36623452-F0B1FD9D-A63B-45BC-A815-21FB73E1B654

P921

Q36623452-BC5A0F52-7655-44B5-93AE-59B7EBACF89E

P932

Q36623452-C1C70BA5-E678-423F-B807-C04E5BE46CCB

P356

P1433

British Journal of Cancer

P1476

Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

@en

P2093

D Parkin

http://www.w3.org/2001/XMLSchema#string

G I Murray

http://www.w3.org/2001/XMLSchema#string

H L McLeod

http://www.w3.org/2001/XMLSchema#string

I D Miller

http://www.w3.org/2001/XMLSchema#string

M E Cruickshank

http://www.w3.org/2001/XMLSchema#string

N E Haites

http://www.w3.org/2001/XMLSchema#string

W T Melvin

http://www.w3.org/2001/XMLSchema#string

P2860

Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?

Therapeutic opportunities from tumour biology in metastatic colon cancer.

The role of cytochrome P450 in tumour development and progression and its potential in therapy.

Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1.

Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.

Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.

17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.

Interaction of anticancer drugs with hepatic monooxygenase enzymes.

Clinical pharmacokinetics of paclitaxel.

The treatment of epithelial ovarian cancer.

P2888

P304

242-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2001.1907

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Morag C E McFadyen

P577

2001-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11881142

http://www.w3.org/2001/XMLSchema#string

P6179

1017956882

http://www.w3.org/2001/XMLSchema#string

P698

11461084

http://www.w3.org/2001/XMLSchema#string

P921

P932

2364045

http://www.w3.org/2001/XMLSchema#string